Joe Kernen is co-anchor of "Squawk Box" (M-F, 6AM-9AM ET), CNBC's signature morning program. It is a fast-paced, irreverent look at the world of Wall Street, and the longest running show on the network. Kernen is based in CNBC's global headquarters in Englewood Cliffs, N.J.
Prior to his anchoring duties, Kernen was CNBC's On-Air Stock Editor and was featured throughout the business day on CNBC.
Kernen came to CNBC in the 1991 merger with Financial News Network, having joined FNN after a 10-year career as a stockbroker. After training at Merrill Lynch, he rose to the level of vice-president at both EF Hutton and Smith Barney. Focusing on small-to-medium-sized corporations, he managed corporate cash accounts and qualified retirement plans in addition to key employees' personal assets.
Kernen holds a bachelor's degree from the University of Colorado in molecular, cellular and developmental biology as well as a master's degree from Massachusetts Institute of Technology. During his graduate studies, he worked at the MIT Center for Cancer Research, one of the world's premier institutions. His work focused on mouse erythroleukemia cells and resulted in a series of publications in well-known scientific journals including CELL, Developmental Biology and Cold Spring Harbor Symposia on Quantitative Biology.
Follow Joe Kernen on Twitter @JoeSquawk.
Martha Stewart does some baking in celebration of Joe Kernen's 25th anniversary at CNBC.
Joe Kernen celebrates 25 years at CNBC.
Jack Welch, author of "The Real-Life MBA: Your No-BS Guide to Winning the Game, Building a Team, and Growing Your Career," weighs in on global economic growth.
Google's self-driving cars are learning to honk, with the "Squawk Box" crew.
CNBC contributor and Politico's chief economic correspondent Ben White, discusses the presidential nomination process.
It's national pot smoking day and there are a lot of myths on the origins of the term "420." "Squawk Box's" Joe Kernen shares one of them.
U.S. Presidential candidate Sen. Ted Cruz joins "Squawk Box" says the U.S. needs growth to function.
Mark Grant, Hilltop Securities, analyzes the economic issues impacting U.S. markets and suggests the best move for the Fed is to leave rates unchanged.
The Cleveland Clinic still has not tested Theranos' blood diagnostic technology, says Dr. Toby Cosgrove.
Markets appear to be wagering a Brexit will either be benign or will not happen, BlackRock's Jeff Rosenberg said.
Avoiding the kinds of conflicts that led to two world wars is the most pressing concern for the EU, George Mitchell says.
The Chinese see "an interesting opportunity" in Donald Trump on a key geopolitical issue, Leland Miller said.
Get the best of CNBC in your inbox